Evidence map›Paper›PMID 24814347›Full record

ArticleNature structural & molecular biology2014

The DNA-binding domain mediates both nuclear and cytosolic functions of p53.

Ariele Viacava Follis, Fabien Llambi, Li Ou, Katherine Baran, Douglas R Green, Richard W Kriwacki

Abstract read
In one paragraph

Article in Nature structural & molecular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Targeting p53 pathways: mechanisms, structures, and advances in therapy.Signal transduction and targeted therapy · 2023
    Pooled it
  2. Article
  3. The ARTS of p53-dependent mitochondrial apoptosis.Journal of molecular cell biology · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. FOXO4 interacts with p53 TAD and CRD and inhibits its binding to DNA.Protein science : a publication of the Protein Society · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Tumor-Suppressor p53TADChembiochem : a European journal of chemical biology · 2020
    Article
  14. Article
  15. iASPP mediates p53 selectivity through a modular mechanism fine-tuning DNA recognition.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  16. MEG3: an Oncogenic Long Non-coding RNA in Different Cancers.Pathology oncology research : POR · 2019
    Review
  17. The Structural Biology of Bcl-xInternational journal of molecular sciences · 2019
    Review
  18. Interaction between p53 N terminus and core domain regulates specific and nonspecific DNA binding.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ariele Viacava FollisDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Fabien LlambiDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Li OuDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Katherine BaranDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Douglas R GreenDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Richard W Kriwacki1] Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. [2] Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Sciences Center, Memphis, Tennessee, USA.

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Structural Determinants in Cell Growth Control by p21 and p27R01CA082491 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KRIWACKI, RICHARD W · 2001 to 2011
$2.7M
BCL2 Family Protein Interactions In Cellular Survival StatesR01GM096208 · NIGMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GREEN, DOUGLAS R. · 2011 to 2018
$2.7M
Understanding the Structural Mechanism of Puma-induced ApoptosisR01GM083159 · NIGMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KRIWACKI, RICHARD W · 2009 to 2012
$1.3M
MECHANISMS OF STRESS-INDUCED APOPTOSIS IN T CELLSR01GM052735 · NIGMS · LA JOLLA INST FOR ALLERGY &IMMUNOLGY · PI GREEN, DOUGLAS R · 1994 to 2001
$594k
NCI NIH HHS P30 CA021765NCI NIH HHS P30CA21765NCI NIH HHS R01 CA082491NCI NIH HHS R01CA082491NIGMS NIH HHS 1R01GM083159NIGMS NIH HHS R01 GM052735NIGMS NIH HHS R01 GM083159NIGMS NIH HHS R01 GM096208NIGMS NIH HHS R01GM52735NIGMS NIH HHS R01GM96208
6 · The paper itself

Abstract

Under conditions of genotoxic stress, human p53 activates the apoptotic effectors BAX or BAK to result in mitochondrial outer-membrane permeabilization and apoptosis. Antiapoptotic BCL-2 family member BCL-xL opposes this activity by sequestering cytosolic p53 via association with its DNA-binding domain, an interaction enhanced by p53 tetramerization. Here we characterized the BCL-xL-p53 complex by NMR spectroscopy and modulated it through mutagenesis to determine the relative contributions of BCL-xL's interactions with p53 or other BCL-2 family proteins to the BCL-xL-dependent inhibition of UV irradiation-induced apoptosis. Under our experimental conditions, one-third of the antiapoptotic activity of BCL-xL was mediated by p53 sequestration and the remaining two-thirds through sequestration of proapoptotic BCL-2 family members. Our studies define the contributions of cytosolic p53 to UV irradiation-induced apoptosis and provide opportunities to explore its contributions to other p53-dependent apoptotic signaling pathways.

Indexed as

Apoptosisbcl-X ProteinBinding SitesCell NucleusCytosolHumansModels, MolecularMutagenesisNuclear Magnetic Resonance, BiomolecularProtein Interaction MappingProtein MultimerizationSignal TransductionTumor Suppressor Protein p53Ultraviolet RaysBCL2L1 protein, humanbcl-X ProteinTumor Suppressor Protein p53

Identifiers

PMID24814347
PMCPMC4134560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.